CSL Behring Announces Availability of Next Generation HeliTrax® System for People with Hemophilia A

 Custom software platform is first internet-enabled mobile application to interface directly with patient management systems used by hemophilia treatment centers


KING OF PRUSSIA, Pa., Dec. 1, 2010 /PRNewswire/ — CSL Behring announced today the availability of the next generation HeliTrax® System as part of a specially designed software platform for Apple’s iPhone®, iPod touch®, or iPad™ devices. This enhanced system is designed to improve therapy management for people with hemophilia A who use CSL Behring’s recombinant factor VIII (rFVIII). Click here for official CSL Behring Release.